Contents

Current Medicinal Chemistry, Volume 24 - Number 40

Editorial

Editorial: VDAC As a Pharmaceutical Target

, 24(40): 4417 - 4418

Angela Messina


DOI: 10.2174/092986732440180104091815




Review Article

VDAC-Targeted Drugs Affecting Cytoprotection and Mitochondrial Physiology in Cerebrovascular and Cardiovascular Diseases

, 24(40): 4419 - 4434

Andonis Karachitos, Joaquin Jordan and Hanna Kmita*


DOI: 10.2174/0929867324666170530073238




Review Article

VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Tar get for Modulating Apoptosis

, 24(40): 4435 - 4446

Varda Shoshan-Barmatz*, Yakov Krelin and Quan Chen


DOI: 10.2174/0929867324666170616105200




Review Article

Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives

, 24(40): 4447 - 4469

Simona Reina* and Vito De Pinto *


DOI: 10.2174/0929867324666170530074039




Review Article

Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules

, 24(40): 4470 - 4487

Andrea Magri* and Angela Messina*


DOI: 10.2174/0929867324666170601073920




Review Article

Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein

, 24(40): 4488 - 4514

Mohammad Abid*, Yogesh A. Sonawane, Jacob I. Contreras, Sandeep Rana and Amarnath Natarajan*


DOI: 10.2174/0929867324666170912092659




Review Article

Chemistry in the Bioactivity of Chlorophylls: An Overview

, 24(40): 4515 - 4536

Antonio Perez-Galvez , Isabel Viera and Maria Roca *


DOI: 10.2174/0929867324666170714102619




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science